LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as $4.09 and last traded at $4.11, with a volume of 575174 shares trading hands. The stock had previously closed at $4.17.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. KeyCorp assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target on the stock. UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target on the stock in a research note on Tuesday, May 27th. Finally, BTIG Research assumed coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They set a "buy" rating and a $8.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, LifeStance Health Group has a consensus rating of "Moderate Buy" and an average target price of $8.42.
View Our Latest Stock Report on LifeStance Health Group
LifeStance Health Group Trading Down 4.8%
The business's fifty day moving average is $4.96 and its 200-day moving average is $6.34. The stock has a market capitalization of $1.47 billion, a PE ratio of -37.90 and a beta of 1.14. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.19.
Insider Transactions at LifeStance Health Group
In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the completion of the sale, the insider directly owned 113,435 shares in the company, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 3.20% of the company's stock.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. DekaBank Deutsche Girozentrale purchased a new position in LifeStance Health Group in the first quarter valued at approximately $31,000. Park Edge Advisors LLC purchased a new position in LifeStance Health Group in the second quarter valued at approximately $52,000. Xponance Inc. purchased a new position in LifeStance Health Group in the first quarter valued at approximately $69,000. Ameriprise Financial Inc. purchased a new position in LifeStance Health Group in the fourth quarter valued at approximately $87,000. Finally, Kapitalo Investimentos Ltda purchased a new position in LifeStance Health Group in the first quarter valued at approximately $87,000. Hedge funds and other institutional investors own 85.50% of the company's stock.
About LifeStance Health Group
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Featured Stories
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access